Medical oncologists, clinical pharmacists, and oncologic nurse practitioners share the presentation topics to look out for at WCLC 2026.
|Slideshows|December 20, 2017
Top Lung Cancer News of 2017
Author(s)Cancer Network Editors
In this slide show we highlight some of the top news on lung cancer in 2017, including FDA approvals, a new standard of care for ALK-positive lung cancer, increased risk with vitamin B supplements, and more.
Advertisement
Advertisement
Related to this article
The interim 3-year OS rates were 71.2% with OST-HER2 vs 45.8% in historical controls in a phase 2b trial of fully resected, pulmonary metastatic osteosarcoma.
Partnering with subspecialities like ophthalmology and dermatology may be critical for nurse practitioners in lung cancer, according to Beth Sandy, CRNP.
Beth Sandy, CRNP, said she would like to see more data on management strategies for blepharitis, eye toxicities, and mucositis in patients with lung cancer.
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves sNDA for Taletrectinib in TKI-Naive Advanced ROS1+ NSCLC
2
IASO208 Receives FDA IND Clearance for Relapsed/Refractory B-Cell Lymphoma
3
SOHO 2026: Key Updates Across the Multiple Myeloma Continuum
4
Secondary T-Cell Malignancies: Identifying and Counseling After CAR T-Cell Therapy
5